C - Chapter VIII: NPN Flashcards

1
Q

FUNCTIONS of the KIDNEYS:
1. Elimination of (?)
2. Elimination of (?) (urea and creatinine)
3. Elimination of (?)like drugs
4. Retention of substances necessary for (?) (proteins & amino acids, glucose)
5. Regulation of (?) of the body fluids)
6. (?) function:

A

excess body water
waste products of metabolism
foreign substances
normal body function
electrolyte balance and osmotic pressure
Endocrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Primary:

A

production of rennin, prostaglandin and erythropoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Secondary:

A

degradation of insulin, glucagon and aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinically Significant NPN compounds:

A
  1. urea – 45%
  2. amino acids – 20%
  3. uric acid – 20%
  4. creatinine – 5 %
  5. creatine – 1-2 %
  6. ammonia – 0.2%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TOTAL NPN METHODOLOGY: TWO STEPS:

A
  1. KJELDAHL DIGESTION
  2. MEASUREMENT OF AMMONIA FORMED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MEASUREMENT OF AMMONIA FORMED

A

A. NESSLERIZATION
B. BERTHELOT METHOD
C. MONITORING CONSUMPTION OF AMMONIA (Kaplan, Manoukian – Fawaz; Kallet – Cook Reaction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

 The nitrogen in a pff of the specimen is converted to ammonia using hot conc. H2SO4 with copper sulfate, mercuric sulfate or selenium oxide as the catalysts.

A

KJELDAHL DIGESTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NPN + H2SO4 NH4HSO4

A

KJELDAHL DIGESTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NH4HSO4 + NaOH Na2SO4 + NH3 + H2O

A

KJELDAHL DIGESTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nessler’s reagent

A

double iodide salt of potassium & mercury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

– colloidal stabilizer

A

Gum ghatti

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

– yellow to orange brown product

A

Dimercuric ammonium iodide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NH3 + HgI2.2KI NH2Hg2I2 + KI + NH4I

A

NESSLERIZATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reagent: phenol and alkaline hypochlorite

A

BERTHELOT METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Catalyst: sodium nitroprusside

A

BERTHELOT METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Product: indophenol blue

A

BERTHELOT METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

NH3 + NaOCl + Phenol Indophenol + NaCl + H2O

A

BERTHELOT METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

NH3 + α – ketoglutarate + NADH + H Glutamate + NAD

A

MONITORING CONSUMPTION OF AMMONIA (Kaplan, Manoukian – Fawaz; Kallet – Cook Reaction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Catalyst: Glutamate dehydrogenase

A

MONITORING CONSUMPTION OF AMMONIA (Kaplan, Manoukian – Fawaz; Kallet – Cook Reaction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Measure a decrease in the absorbance at 340 nm

A

Glutamate dehydrogenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  • most abundant NPN compound in plasma
A

UREA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  • major excretory product of protein metabolism
A

UREA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  • synthesized in the liver from CO2 and ammonia that arises from the deamination of amino acids in the reaction of the urea cycle
A

UREA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

UREA STRUCTURE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
UREA MW
60 g/mole
26
UREA MW = 60 g/mole C = H = O = N =
C = 1 x 12 = 12 H = 4 x 1 = 4 O = 1 x 16 = 16 N = 2 x 14 = 28
27
From urea mass units to urea nitrogen (28/60) =
0.467
28
From urea nitrogen to urea mass units (60/28) =
2.14
29
- [?] excreted through the kidneys
90%
30
- excreted through the skin and GIT
10%
31
- [?] reabsorbed in the renal tubules by passive diffusion
40 – 70%
32
Urea concentration depends on the following :
1. renal function and perfusion 2. protein content of the diet 3. amount of protein catabolism
33
METHODS FOR UREA DETERMINATION
I. INDIRECT METHOD / ENZYMATIC II. DIRECT METHODS
34
INDIRECT METHOD / ENZYMATIC
1. Berthelot reaction 2. Nessler’s reaction 3. GLDH-coupled enzymatic method (Dupont ACA Analyzer) 4. Conductimetric method: Beckman BUN Analyzer 5. Urograph or Urastrat strip 6. Indicator dye (uriol): Kodak Ectachem Analyzer
35
DIRECT METHODS
1. Diacetyl Monoxime (Fearon) 2. ortho – phthaldehyde: adapted by automated methods
36
measures Blood Urea Nitrogen
INDIRECT METHOD / ENZYMATIC
37
Based on the preliminary hydrolysis of urea with urease followed by some process that quantitates the ammonium ion
INDIRECT METHOD / ENZYMATIC
38
Decrease in absorbance of NAD at 340 nm
39
➢ Based on the measurement of the conductivity generated from the reaction of urease on urea producing ammonium ions & bicarbonates
Conductimetric method: Beckman BUN Analyzer
40
➢ Physical principle: based on chromatography
Urograph or Urastrat strip
41
➢ Chemical principle: Conway Microdiffusion method
Urograph or Urastrat strip
42
➢ Dye is added to NH4 ions from urea hydrolysis & the color change is measured
Indicator dye (uriol): Kodak Ectachem Analyzer
43
➢ Used in multilayer film reagents, dry reagent strips and automated systems
Indicator dye (uriol): Kodak Ectachem Analyzer
44
➢ Direct condensation reaction
DIRECT METHODS
45
➢ Diacetyl – very toxic
DIRECT METHODS
46
Urea + OP Isoindoline
ortho – phthaldehyde: adapted by automated methods
47
Isoindoline + Naphthylethylenediamine colored compound
ortho – phthaldehyde: adapted by automated methods
48
– a biochemical abnormality pertaining to increase NPN compounds especially creatinine and urea defining GFR defect
Azotemia
49
– due to reduced renal blood flow
a. prerenal
50
– decreased renal function
b. renal
51
– obstruction of urine flow
c. postrenal
52
Azotemia Three categories:
a. prerenal b. renal c. postrenal
53
> calculi, tumors of bladder or prostate
c. postrenal
54
> kidney diseases: glomerular nephritis
b. renal
55
> hemorrhage, dehydration, increased protein catabolism
a. prerenal
56
– a clinical syndrome characterized by increased BUN accompanying renal failure seen in metabolic acidosis, hyperkalemia and edema
Uremia/ Uremic syndrome
57
Decreased Urea: -
decreased protein intake, severe vomiting and diarrhea
58
Specimen Requirements and Interfering Substances 1. plasma, [?], or [?] 2. plasma : [?] and high concentrations of [?] and [?] must be avoided 3. [?] is acceptable 4. [?] is recommended 5. urine sample guarded against bacterial decomposition of [?]
serum or urine ammonium ions; sodium citrate and sodium fluoride non fasting sample nonhemolyzed sample urea
59
Reference Interval: − adult serum/plasma
6-20 mg/dL 2.1-7.1 mmol/L
60
Reference Interval: − conversion factor mg/dL ---> mmol/L :
0.357
61
Reference Interval: - urine, 24hr
12-20 g/day 0.43-0.71 mol/day
62
- principal waste product of muscle metabolism derived mainly from Creatine (alphamethylguanidinoacetate
CREATININE
63
Creatine is produced from two enzymatic processes:
o transamination of arginine & lysine forming guanidinoacetic acid in the kidneys, small intestines, pancreas and probably the liver o methylation of guanidinoacetic acid in the liver
64
is the muscles’ energy source
Creatine PO4
65
RENAL HANDLING of CREATININE: 1. Glomerular filtration 2. Excreted without being reabsorbed. Thus, excretion is relatively constant. Creatinine output is sometimes used to measure the completeness of a 24-hour urine sample collection 3. When serum creatinine is elevated, it is secreted in the renal tubules
66
ANALYTICAL METHODS
1. DIRECT METHOD: JAFFE REACTION 2. INDIRECT / ENZYMATIC METHODS 3. Yatzidis method 4. High Performance Liquid Chromatography (HPLC)
67
Creatinine + alkaline picrate Creatinine picrate (red orange/yellow) 510 nm
DIRECT METHOD: JAFFE REACTION
68
Alkaline picrate:
1 part 10% NaOH and 5 parts sat. picric acid (2,4,6 trinitrophenol)
69
lacks specificity
Jaffe reaction
70
Non-creatinine Jaffe-reacting chromogens:
- Proteins - Glucose - Ascorbic acid - Guanidine - Acetone - Cephalosporins - α-ketoacids (acetoacetate and pyruvate)
71
INDIRECT / ENZYMATIC METHODS
a. F. Lim – Creatininase or creatinine iminohydrolase b. G.A. Moss – Creatinine Amidohydrolase
72
Creatinine ----------------→ N-methylhydantoin + NH3 (Creatininase)
F. Lim – Creatininase or creatinine iminohydrolase
73
NH3 + α-ketoglutarate + NADH -----------------→ glutamate + NAD + H+ (Glutamate DH)
F. Lim – Creatininase or creatinine iminohydrolase
74
Creatinine -----------------------------------→ Creatine (Creatinine amidohydrolase)
G.A. Moss – Creatinine Amidohydrolase
75
Creatine + ATP ------------------→ CreatinePO4 + ADP (Creatine kinase)
G.A. Moss – Creatinine Amidohydrolase
76
ADP + PEP ------------------→ Pyruvate + ATP (Pyruvate kinase)
G.A. Moss – Creatinine Amidohydrolase
77
Pyruvate + NADH + H+ ---------------→ Lactate + NAD (Lactate DH)
G.A. Moss – Creatinine Amidohydrolase
78
Creatinine reacts with alkaline picrate at two different pH levels
Yatzidis method
79
: protein & other interfering materials will reacts w/ picrate but creatinine does not
pH 10
80
: both creatinine & proteins react
pH 11
81
High Performance Liquid Chromatography (HPLC) Sources of error :
1. ascorbate, glucose, alpha keto acids and uric acid 2. drugs
82
false increase
ascorbate, glucose, alpha keto acids and uric acid cephalosporin and dopamine intake lidocaine intake
83
CREATININE Specimen Requirements and Interfering Substances 3. plasma, [?] 4. avoid [?] especially for the Jaffe reaction 5. [?] cause errors 6. [?] acceptable 7. [?] may transiently elevate serum concentrations 8. [?] : refrigerated after collection or frozen if longer storage than 4 days is required
serum or urine hemolyzed and icteric sample lipemic samples non-fasting sample high protein ingestion urine
84
3. overestimates but gives a reasonable approximation of glomerular filtration rate
Creatinine Clearance
85
expressed in mL/minute
Creatinine Clearance
86
plasma concentration of creatinine is inversely proportional to creatinine clearance (elevated creatinine clearance = decreased GFR)
Creatinine Clearance
87
insensitive marker: >50% renal dysfunction = abnormal plasma creatinine
Creatinine Clearance
88
Creatinine Clearance =
U x V / P
89
− used in the diagnosis of muscle diseases
Creatine kinase
90
: CREATININE RATIO
BUN
91
NORMAL CREATININE RATIO :
10–20:1
92
a. Acute tubular necrosis
BUN:CREA ratio <10:1
93
b. Low protein intake; starvation
BUN:CREA ratio <10:1
94
c. Severe liver disease
BUN:CREA ratio <10:1
95
d. Repeated dialysis
BUN:CREA ratio <10:1
96
e. Severe vomitting or diarrhea
BUN:CREA ratio <10:1
97
a. Catabolic states w/ tissue breakdown
BUN:CREA ratio >10:1 with normal creatinine
98
b. Pre-renal azotemia
BUN:CREA ratio >10:1 with normal creatinine
99
c. High protein intake
BUN:CREA ratio >10:1 with normal creatinine
100
d. After GIT hemorrhage
BUN:CREA ratio >10:1 with normal creatinine
101
High ratio with elevated creatinine levels
✓ Post-renal obstruction ✓ Pre-renal azotemia superimposed on renal disease
102
is MORE SPECIFIC for the diagnosis of renal disease
Creatinine determination
103
is MORE SENSITIVE for the diagnosis of renal disease
BUN determination
104
ASSOCIATED MYOPATHIES:
− muscular dystrophy − familial periodic paralysis − myasthenia gravis − dermatomycosis
105
Reference Interval (1) plasma/serum 5. Jaffe: adult female
0.6-1.1 mg/dL (53-97 µmol/L)
106
Reference Interval (1) plasma/serum 5. Jaffe: adult male
0.9-1.3 mg/dL (80-115 µmol/L)
107
Reference Interval (2) 24h urine adult female
600-1800 mg/day 5.3-15.9 mmol/day
108
Reference Interval (2) 24h urine adult male
800-2000 mg/day 7.1-17.7 mmol/day
109
Reference Interval (1) plasma/serum 6. Enzymatic: adult male
0.6-1.1 mg/dL (53-97 µmol/L)
110
Reference Interval (1) plasma/serum 6. Enzymatic: adult female
0.5-0.8 mg/dL (44-71 µmol/L)
111
− major product of the catabolism of purine nucleosides: adenosine & guanosine
URIC ACID
112
− formed in the liver & intestinal mucosa from xanthine
URIC ACID
113
− The bulk of purines ultimately excreted as uric acid in the urine arises from degradation of endogenous nucleic acids.
URIC ACID
114
− Reutilization of the major purine bases (adenine, hypoxanthine and guanine) is achieved through “salvage” pathways
URIC ACID
115
[?] of the free bases causes re-synthesis of the respective nucleotide monophosphates
Phosphoribosylation
116
• 75% is excreted through the urine
URIC ACID
117
The remainder is secreted into the GIT, where it is degraded to allantoin & other compounds by bacterial enzymes.
− Glomerular filtration ' − Tubular reabsorption in the PCT: 98 – 100% − Active secretion − Reabsorption in the DCT − Net excretion: 10%
118
RENAL HANDLING of URIC ACID FACTORS 1. Diet: [?] 2. Age & gender: increase w/ age; higher in [?] 3. 2x greater concentration in [?] than in plasma 4. Avoid the use of [?] because it forms salts that cause turbidity 5. UA is stable in [?] for several days at RT and longer at ref. temp. 6. [?] increases its stability
legumes, seeds, internal organs males RBC K oxalate serum Thymol
119
Uric Acid + PTA ------- OH-------- Allantoin + CO2 + Tungsten blue (710 nm)
DIRECT METHOD: Phosphotungstic Acid (PTA)
120
DIRECT METHOD: Phosphotungstic Acid (PTA) Alkaline solution: NaCN: Folin Na2CO3: Caraway Brown Henry Benedict Archibald Newton
121
Uric Acid Allantoin + CO2
Blaunch and Koch (UV test with uricase)
122
The decrease in the UA concentration is determined by measuring the absorbance in the range of 290 – 300 nm
Blaunch and Koch (UV test with uricase)
123
Uric Acid + O2 + 2H2O Allantoin + CO2 + H2O2
Trinder – Uricase method
124
H2O2 + DHBS + PAP Quinoneimine derivative (480 – 550 nm)
Trinder – Uricase method
125
DHBS: 3,5 – dichloro – 2- dihydroxy benzene sulfonic acid
Trinder – Uricase method
126
PAP: 4 – aminophenazone
Trinder – Uricase method
127
Uric Acid Allantoin + CO2 + H2O2
Uricase – catalase system
128
H2O2 + methanol ---------------→ formaldehyde + H2O (Catalase)
Uricase – catalase system
129
Formaldehyde + acetylacetone + NH3 3H2O + 3,5-diacetyl-1,4- dihydrolutidine (410 nm)
Uricase – catalase system
130
H2O2 + ethanol ---------------→ Acetaldehyde + H2O (Catalase)
Uricase – catalase system
131
Acetaldehyde + NAD ---------------→ Acetate + NADH (increase in Abs at 340 nm) (Aldehyde DH)
Uricase – catalase system
132
Cupric ions -----UA---→ Cuprous ions
Bittner method
133
Cuprous ions + neocuproine copper neocuproine complex (yellow to orange)
Bittner method
134
Ferric ions -----UA---→ Ferrous ions
135
Ferrous ions + TPTZ blue colored complex (590 nm)
TPTZ Method by Morin
136
TPTZ : 2,4,6- tripyridyl – 5 – triazine
TPTZ Method by Morin
136
TPTZ : 2,4,6- tripyridyl – 5 – triazine
TPTZ Method by Morin
137
OTHER METHODS:
A. HPLC B. Amperometric Principle: Polarographic method
138
URIC ACID DISEASE CORRELATIONS:
(1) HYPERURICEMIA (2) HYPOURICEMIA
139
HYPERURICEMIA A. Increased Formation Primary:
- Idiopathic - Inherited metabolic disorders
140
HYPERURICEMIA A. Increased Formation Secondary:
- Excess dietary purine intake - Increased nuclear breakdown (e.g. Leukemia) - Psoriasis - Altered ATP metabolism - Tissue hypoxia - Pre-eclampsia - Alcohol
141
HYPERURICEMIA B. Decreased Formation Primary:
- Idiopathic
142
HYPERURICEMIA B. Decreased Formation Secondary:
- Renal failure - Drug therapy: salicylate - Poisons: heavy metal - Pre-eclampsia - Organic acids - Trisomy 21 (Down syndrome)
143
Hereditary Hyperuricemia:
 Lesch-Nyhan syndrome  Abnormal phosphoribosyl pyroPO4 synthetase
144
: x-linked genetic disorder; deficiency of hypoxanthine guanine phosphoribosyl transferase (muricase)
Lesch-Nyhan syndrome
145
: prevents reutilization of purine bases in the nucleotide salvage pathway
Abnormal phosphoribosyl pyroPO4 synthetase
146
: monosodium urate precipitates from supersaturated body fluids
GOUT
147
: o Atrophy of the liver
HYPOURICEMIA
148
Specimen Requirements and Interfering Substances − heparinized plasma, serum or urine − immediate separation from red cells to prevent dilution by intracellular contents − non-fasting sample acceptable − gross lipemia should be avoided − high bilirubin may cause false decrease − significant hemolysis will lower results − drugs : salicylates and thiazides : false increase
149
Reference Interval (uricase method) Adult female plasma or serum
2.6-6.0 mg/dL (0.16-0.36 mmol/L)
150
Reference Interval (uricase method) Adult male urine, 24h
250-750 mg/day (1.48-4.43 mmol/day)
151
Reference Interval (uricase method) Child plasma or serum
2.0-5.5 mg/dL (0.12-0.33 mmol/L)
152
Reference Interval (uricase method) Conversion factor:
0.059
153
Reference Interval (uricase method) Adult male plasma or serum
2.5-7.2 mg/dL (0.21-0.43 mmol/L)
154
− from deamination of amino acids thru the action of digestive and bacterial enzymes on proteins in the GIT
AMMONIA
155
− used in the liver for urea production
AMMONIA
156
− level in circulation is extremely low (15 – 45 µg/dL)
AMMONIA
157
− increased in concentration in the blood in cases of severe liver damage
AMMONIA
158
− most ammonia in the blood exists as ammonium ion
AMMONIA
159
− concentration is not dependent on renal function
AMMONIA
160
− high ammonia :
neurotoxic --- encephalopathy
161
METHODS for AMMONIA DETERMINATION:
1. Conway and Cook Diffusion Method 2. Forman’s Resin Absorption Method 3. Kunahashi, Ishihora and Euhera Method 4. Van Anken Enzymatic Method 5. Ion Selective Electrode
162
SOURCES OF AMMONIA CONTAMINATION:
1. Smoking 2. Laboratory atmosphere 3. Poor venipuncture technique 4. Metabolism of nitrogenous constituents
163
• specimen is alkalinized to convert NH4 ions to NH3
Conway and Cook Diffusion Method
164
• NH3 is trapped in acid medium of diffusion cell
Conway and Cook Diffusion Method
165
• Quantitated by titration or colorimetry
Conway and Cook Diffusion Method
166
• Time consuming with poor accuracy and precision
Conway and Cook Diffusion Method
167
• Uses cation-exchange resin
Forman’s Resin Absorption Method
168
• NH3 absorbed by the resin and eluted
Forman’s Resin Absorption Method
169
• Quantitated by Berthelot reaction or by Nesslerization
Forman’s Resin Absorption Method
170
Forman’s Resin Absorption Method N.V.:
16 – 33 µmol/L
171
• NH3 is obtained through the use of a Dowax column
Kunahashi, Ishihora and Euhera Method
172
• Assayed using the Berthelot method
Kunahashi, Ishihora and Euhera Method
173
2-oxoglutarate + NH4+ + NADPH Glutamate + NADP + H2O
Van Anken Enzymatic Method
174
Van Anken Enzymatic Method N.V.:
11 – 35 µmol/L
175
• Based on the diffusion of NH3 through a selective membrane into NH4 chloride causing pH change which is determined potentiometrically
Ion Selective Electrode
176
• Good precision and accuracy
Ion Selective Electrode
177
SOURCES OF AMMONIA CONTAMINATION:
1. Smoking 2. Laboratory atmosphere 3. Poor venipuncture technique 4. Metabolism of nitrogenous constituents
178
Metabolism of nitrogenous constituents Minimized by:
o placing the specimen in ice water o centrifuging w/o delay o performing the assay immediately
179
 Use of heparin lock
Poor venipuncture technique
180
 Probing for a vein
Poor venipuncture technique
181
 Partial fill of the evacuated tube
Poor venipuncture technique
182
 Drawing blood into a syringe & transferring it into an anti-coagulated tube
Poor venipuncture technique
183
 Blood collection & NH3 analysis must be done in a lab w/ restricted traffic
Laboratory atmosphere
184
 Glassware: soaked in hypochlorite solution (52.5g/L)
Laboratory atmosphere
185
AMMONIA CLINICAL SIGNIFICANCE
I. PRIMARY OR INHERITED HYPERAMMONEMIA II. ACQUIRED HYPERAMMONEMIA
186
A. Enzyme defects in the Kreb’s Henseleit Cycle
PRIMARY OR INHERITED HYPERAMMONEMIA
187
B. Defects in the metabolism of amino acids: Lysine & Ornithine
PRIMARY OR INHERITED HYPERAMMONEMIA
188
C. Defects in the metabolism of: Propionic acid Methylmalonic acid Isovaleric acid
PRIMARY OR INHERITED HYPERAMMONEMIA
189
A. Severe liver disease
ACQUIRED HYPERAMMONEMIA
190
B. Impaired venous drainage (from intestine to liver by portal vein)
ACQUIRED HYPERAMMONEMIA
191
C. Impaired renal excretion
ACQUIRED HYPERAMMONEMIA
192
Severe liver disease: o Acute – o Chronic –
toxic or fulminant viral hepatitis & Reye’s syndrome cirrhosis
193
from intestine to liver by portal vein
Impaired venous drainage
194
Impaired renal excretion Decreased (?) Increased (?) increased excretion of (?) into intestines converted to (?)
urine output BUN reabsorbed urea; ammonia
195
AMMONIA Reference Interval adult plasma
19-60 ug/dL 11-35 umol/L
196
AMMONIA Reference Interval adult urine,24h
140-1500 mg N/day 10-107 mmol N/day
197
Reference Interval child 10days to 2y
68-136 ug/dL 40-80 umol